
When diet and exercise stop producing the results they used to, medical weight loss can give you another path forward. Valora connects you with licensed clinicians and modern weight-loss treatments, including semaglutide and tirzepatide when appropriate.
Your clinician determines what is appropriate for you. Start by comparing the two treatments most Valora weight-loss patients ask about.

Dual GIP / GLP-1 receptor agonist
Tirzepatide acts on two gut-hormone pathways involved in appetite and blood-sugar regulation. Many patients ask about it for slower gastric emptying and reduced hunger signalling. Individual responses vary.
Starting at$349
Prescription treatment requires clinician review. Eligibility is not guaranteed.

GLP-1 receptor agonist
Semaglutide mimics the GLP-1 hormone your body already makes, supporting satiety and appetite regulation. It is the most widely asked-about medical weight-loss molecule. Individual responses vary.
Starting at$299
Prescription treatment requires clinician review. Eligibility is not guaranteed.
A side-by-side look at how the two differ. Neither is universally “better” — the right choice is a clinical decision.
| Tirzepatide | Semaglutide | |
|---|---|---|
| Mechanism | Dual GIP / GLP-1 receptor agonist | GLP-1 receptor agonist |
| Starting price | $349 | $299 |
| Prescription required | Yes — clinician review required | Yes — clinician review required |
| Best fit | Determined by your clinician based on health history, goals, tolerance and availability. | |
Cutting portions, walking more, another round of the plan that worked in your thirties — and the scale barely moves. Weight comes back after every stretch of discipline. Clothes fit differently. You stop wanting to be in the photo.
That is not a character problem. Body weight is shaped by biology as much as behavior: hunger and satiety hormones, sleep, stress, medications, and the metabolic shifts that come with midlife. Willpower does not override any of that on its own.
For eligible patients, prescription therapies can work alongside nutrition, movement and clinical follow-up — addressing the signalling side of the problem while you do the rest. A licensed clinician decides whether that is appropriate for you.
Three steps, no clinic waiting room.
Start the online assessment and share your health history, medications and goals.
A clinician reviews your history and determines whether treatment is appropriate for you.
If prescribed, your treatment is fulfilled through a U.S. pharmacy and your care continues from there.
The four questions we hear most, answered plainly.
Valora connects you with licensed clinicians. If treatment is prescribed, it is fulfilled through a U.S. pharmacy — not shipped from an unverified source.
Starting prices are shown on this page and on every product page, straight from our store. You see the price before you commit to anything.
Side effects are possible with any prescription therapy. Your clinician reviews your history first, and dosing is adjusted over time with ongoing check-ins rather than left to you to manage alone.
That is a clinical decision. Your clinician weighs your health history, goals, tolerance and availability — this page is here to help you compare, not to diagnose.
Tirzepatide vs. semaglutide, cost, side effects, eligibility, plateaus, muscle preservation and long-term maintenance.
Two of the most powerful weight loss medications available today work differently — here's how to know which one fits your body, goals, and history.
Read articleMost patients hit a weight loss plateau on semaglutide or tirzepatide. It's not failure — it's biology. Here's the playbook for getting moving again.
Read articleNausea, constipation, fatigue — the most common GLP-1 side effects are predictable, time-limited, and largely manageable with the right protocol.
Read articleBMI thresholds, comorbidities, contraindications — a clear breakdown of who is a candidate for semaglutide or tirzepatide and who is not.
Read article
Wegovy, Zepbound, and compounded semaglutide all contain the same active molecule — but they're not the same product. Here's what changes and what doesn't.
Read articleThe data is clear: stop GLP-1s cold and most patients regain. Here's the evidence on maintenance protocols, microdosing, and the metabolic transition off therapy.
Read articleRoughly 25–40% of weight lost on a GLP-1 is lean mass. Here's what that means clinically, and the protein and training protocol that protects it.
Read articleSub-therapeutic GLP-1 dosing has become a popular maintenance and longevity strategy. Here's where the evidence supports it and where it gets ahead of the data.
Read articleCompare Valora’s weight-loss options and take the next step toward clinician-guided care.
See My Weight-Loss Options